Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.56 USD | +4.81% | -0.58% | -50.98% |
02/05 | North American Morning Briefing : Stock Futures -2- | DJ |
01/05 | UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.98% | 3.15B | |
-1.89% | 12.5B | |
-9.59% | 7.67B | |
+21.33% | 5.36B | |
-1.31% | 5.26B | |
+0.02% | 4.57B | |
+6.42% | 2.59B | |
-10.02% | 2.06B | |
-8.29% | 1.79B | |
+2.77% | 1.74B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- Goldman Sachs Downgrades 10x Genomics to Sell From Neutral, Lowers Price Target to $35 From $55